ANAB AnaptysBio, Inc.
Healthcare$59.71-1.16%ClosedMarket Cap: $2.57B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$83.14
Target (Median)
$76.00
Target Range
$50.00 - $140.00
Upside from current price: 39.2%
Rating Distribution
3 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Barclays | maintain | Overweight | Overweight |
| 2026-05-13 | UBS | maintain | Buy | Buy |
| 2026-05-04 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-04-28 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-03-31 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-17 | UBS | maintain | Buy | Buy |
| 2026-03-12 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-09 | Truist Securities | maintain | Hold | Hold |
| 2026-03-05 | Stifel | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.34 | $172.0M | 4 |
| Sun Dec 31 | $5.26 | $296.7M | 5 |
| Mon Dec 31 | $5.42 | $359.6M | 1 |
| Tue Dec 31 | $7.15 | $473.4M | 1 |